About: Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoimmune diseases. Its lead clinical-stage candidate, claseprubart, a monoclonal antibody engineered with extended half-life, improved potency, and high selectivity for only the active C1s complement protein; and DNTH212, a bifunctional fusion protein that targets plasmacytoid dendritic cell (pDC) BDCA2 to reduce Type 1 interferon production, while simultaneously inhibiting BAFF/APRIL to suppress B cell function. Dianthus Therapeutics, Inc. was founded in 2019 and is headquartered in New York, New York.
Sector: Healthcare
Industry: Biotechnology
Latest price: $76.78 (-2.23%)
DNTH NASDAQ Dianthus Therapeutics Inc.
Dianthus Therapeutics Inc. share price
DNTH price activity
Last Price
$76.780
Change (24hr)
-1.75 USD (2.23%)
Volume
379.06K
Volume (4w avg)
-
Open
$76.03
Day Range
$76.03 - $78.16
Previous Close
$78.53
Last Trade
23 Oct, 8:00 pm GMT+0
Delayed
23 Oct, 8:00 pm GMT+0
DNTH price performance
Delayed
23 Oct, 8:00 pm GMT+0
DNTH Market Signals